(Q33339673)
Statements
1 reference
Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG). (English)
1 reference
C J Punt
1 reference
P Fumoleau
1 reference
B van de Walle
1 reference
M N Faber
1 reference
M Ravic
1 reference
M Campone
1 reference
1 September 2001
1 reference
1 reference
12
1 reference
1289-1293
1 reference
Identifiers
1 reference
1 reference